The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.

about

Autoimmunity in 2016.Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.Skeletal complications of rheumatoid arthritis.

P2860

Q39337341-48A8A2C6-4397-4D37-BC5E-F3F5D185F4DF Q45796102-5332D15A-118C-42C4-9C57-A258B2C788BD Q47805955-44425C64-02A3-44B6-AB08-69A68C894723

P2860

The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.

Item

http://www.wikidata.org/entity/Q38831693

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Impact of Conventional and ...... oid Arthritis as a Case Study.

@en

type

Item

label

The Impact of Conventional and ...... oid Arthritis as a Case Study.

@en

prefLabel

The Impact of Conventional and ...... oid Arthritis as a Case Study.

@en

P1476

The Impact of Conventional and ...... oid Arthritis as a Case Study.

@en

P2093

João Eurico Fonseca

http://www.w3.org/2001/XMLSchema#string

Sofia Carvalho Barreira

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate

Effects of anti-tumor necrosis factor α agents on bone

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies

Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort

Chronic arthritis leads to disturbances in the bone collagen network.

Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study.

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

P2888

s12016-016-8547-6

P304

100-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S12016-016-8547-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022560760

http://www.w3.org/2001/XMLSchema#string

P698

27166684

http://www.w3.org/2001/XMLSchema#string

The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.

about

P2860

P2860

The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698